180
Views
3
CrossRef citations to date
0
Altmetric
Perspective

Integrating stereotactic body radiation therapy in stage II/III non-small cell lung cancer: is local control important?

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

M. Kandi, L. Hoffmann, D. Sloth Moeller, H. H. Schmidt, M. M. Knap & A. A. Khalil. (2018) Local failure after radical radiotherapy of non-small cell lung cancer in relation to the planning FDG-PET/CT. Acta Oncologica 57:6, pages 813-819.
Read now

Articles from other publishers (2)

Tanja Eichkorn, Jonathan W. Lischalk, Cedric Stüwe, Eric Tonndorf-Martini, Kai Schubert, Lisa-Antonia Dinges, Sebastian Regnery, Farastuk Bozorgmehr, Laila König, Petros Christopoulos, Juliane Hörner-Rieber, Sebastian Adeberg, Klaus Herfarth, Hauke Winter, Michael Thomas, Stefan Rieken, Jürgen Debus & Rami A. El Shafie. (2023) High-risk patients with locally advanced non-small cell lung cancer treated with stereotactic body radiation therapy to the peripheral primary combined with conventionally fractionated volumetric arc therapy to the mediastinal lymph nodes. Frontiers in Oncology 12.
Crossref
Nazmus Sakib, Na Li, Xiaoxia Zhu, Dianhe Li, Yiyi Li & Haofei Wang. (2018) Effect of postoperative radiotherapy on outcome in resectable stage IIIA-N2 non-small-cell lung cancer. Nuclear Medicine Communications 39:1, pages 51-59.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.